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ORIGINAL RESEARCH
Association Between Diagnosis Code 
Expansion and Changes in 30- Day Risk- 
Adjusted Outcomes for Cardiovascular 
Diseases
Lauren Gilstrap , MD, MPH; Rishi K. Wadhera , MD, MPP; Andrea M. Austin, PhD;  
Stephen Kearing, MS; Karen E. Joynt Maddox , MD, MPH; Robert W. Yeh , MD, MBA
BACKGROUND: In January 2011, Centers for Medicare and Medicaid Services expanded the number of inpatient diagnosis codes 
from 9 to 25, which may influence comorbidity counts and risk- adjusted outcome rates for studies spanning January 2011. 
This study examines the association between (1) limiting versus not limiting diagnosis codes after 2011, (2) using inpatient- only 
versus inpatient and outpatient data, and (3) using logistic regression versus the Centers for Medicare and Medicaid Services 
risk- standardized methodology and changes in risk- adjusted outcomes.
METHODS AND RESULTS: Using 100% Medicare inpatient and outpatient files between January 2009 and December 2013, we 
created 2 cohorts of fee- for- service beneficiaries aged ≥65 years. The acute myocardial infarction cohort and the heart failure 
cohort had 578 728 and 1 595 069 hospitalizations, respectively. We calculate comorbidities using (1) inpatient- only limited 
diagnoses, (2) inpatient- only unlimited diagnoses, (3) inpatient and outpatient limited diagnoses, and (4) inpatient and outpa-
tient unlimited diagnoses. Across both cohorts, International Classification of Diseases, Ninth Revision (ICD- 9) diagnoses and 
hierarchical condition categories increased after 2011. When outpatient data were included, there were no significant differ-
ences in risk- adjusted readmission rates using logistic regression or the Centers for Medicare and Medicaid Services risk 
standardization. A difference- in- differences analysis of risk- adjusted readmission trends before versus after 2011 found that 
no significant differences between limited and unlimited models for either cohort.
CONCLUSIONS: For studies that span 2011, researchers should consider limiting the number of inpatient diagnosis codes to 
9 and/or including outpatient data to minimize the impact of the code expansion on comorbidity counts. However, the 2011 
code expansion does not appear to significantly affect risk- adjusted readmission rate estimates using either logistic or risk- 
standardization models or when using or excluding outpatient data.
Key Words: acute myocardial infarction ■ heart failure ■ medicare ■ outcomes
In January 2011, the Centers for Medicare and Medicaid Services (CMS) expanded the number of available secondary diagnosis codes from 9 to 25 
for inpatient hospitalizations.1 Since then, 2 analyses 
have suggested that not accounting for this expansion 
in diagnosis codes may bias comorbidity counts and 
estimates of risk- adjusted readmission rates.2,3 Another 
analysis found that this expansion was associated with a 
statistically significant increase in the measured severity 
of illness among diagnoses targeted by readmission- 
based incentive programs.4 This has led some to ad-
vocate for limiting the number of diagnostic codes after 
January 2011 to 9,3,5 whereas others have argued that 
there is no need to limit diagnosis codes if outpatient 
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data are also included.6– 8 At present, little is known 
about the association between limiting versus not lim-
iting diagnosis codes after 2011 and whether adding 
outpatient data influences this for acute myocardial in-
farction (AMI) and heart failure (HF). Understanding the 
associations between diagnosis code limits and data 
sources with comorbidity assessment and estimates of 
30- day risk- adjusted readmission rates is important in 
comparing evaluations of policy interventions that span 
January 2011, most notably the Hospital Readmissions 
Reduction Program.9– 12
Another factor to consider in comparing evaluations of 
policy interventions, such as the Hospital Readmissions 
Reduction Program, is the methodology used to risk ad-
just outcomes. Specifically, the 2 studies published to date 
that have questioned the reduction in readmission rates 
after the Hospital Readmissions Reduction Program used 
logistic regression models to risk adjust readmission rates 
for standard demographics, admission dates, and comor-
bidities.2,3 In contrast, the CMS uses a complex hierar-
chical logistic regression to calculate a risk- standardized 
readmission rate as the ratio of “predicted” over “expected” 
readmissions/deaths and then multiplies each hospital’s 
ratio by the national unadjusted rate. To date, whether the 
2 methodologies produce different results and/or are af-
fected differently by changes in diagnosis codes and the 
type of data used has not been explored.
The aim of this study is therefore 2- fold: (1) exam-
ine the association between limiting versus not limiting 
diagnosis codes and inpatient- only versus inpatient 
and outpatient data with changes in calculated risk- 
adjusted 30- day readmission rates and (2) determine 
the difference in risk- adjusted readmission rates cal-
culated using standard logistic regression versus the 
CMS risk- standardized methodology and determine 
whether they are differentially sensitive to changes in 
diagnoses code counts or data sources.
METHODS
This project was reviewed and approved by the 
Dartmouth- Hitchcock Medical Center Institutional 
Review Board. This article is compliant with the 
Strengthening the Reporting of Observational Studies 
in Epidemiology reporting guideline for observational 
studies. The authors declare that all supporting data 
are available within this article and its online supple-
mentary files. All analyses were performed between 
November 2019 and December 2020 using SAS 9.4.
Study Cohorts
We used 100% Medicare Parts A and B and 100% 
outpatient data to create 2 cohorts of beneficiar-
ies aged ≥65 years with ≥1 admission for AMI or HF 
between 2009 and 2013. Using the CMS published 
methodologies, we created an AMI readmission and a 
HF readmission cohort (Figure S1).13 Beneficiaries were 
required to have 12  months of fee- for- service cover-
age before their AMI or HF admission. Beneficiaries 
with unknown age or sex, those enrolled in Medicare 
for <12  months, those discharged against medical 
advice, those who died before discharge, and those 
who underwent implantation of a left ventricular assist 
device or heart transplant during admission or in the 
12 months before admission were excluded.14
Calculating Hierarchical Condition 
Categories (Comorbidities) for Risk 
Adjustment
To determine the number of hierarchical condition 
comorbidities (HCCs)15 per patient to include in the 
CLINICAL PERSPECTIVE
What Is New?
• In January 2011, the Centers for Medicare and 
Medicaid Services expanded the number of in-
patient diagnosis codes from 9 to 25; this had 
led to concerns about the stability of comorbid-
ity counts and risk- adjusted outcome rates for 
studies that span 2011.
• To address this, some have recommend limiting 
the number of inpatient diagnosis codes to 9 
for studies that span 2011, whereas others have 
recommended including outpatient data as a 
way of mitigating the impact of the diagnosis 
code expansion.
• In this study, we found an increase in comor-
bidity counts after 2011 but no significant differ-
ence in risk- adjusted outcomes rates between 
models that limited the number of diagnosis 
codes to 9 versus those that did not or between 
models that used inpatient- only data versus in-
patient and outpatient data.
What Are the Clinical Implications?
• For studies that span 2011, diagnosis codes 
may need to be limited for studies that use 
comorbidity counts, but the 2011 code ex-
pansion does not appear to significantly affect 
risk- adjusted readmission rate estimates using 
either logistic or risk- standardization models.
Nonstandard Abbreviations and Acronyms
CMS Centers for Medicare and Medicaid 
Services
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readmission models, we used the following 4 different 
approaches/methods:
1. Inpatient- only data with diagnostic codes limited 
to 9 after 2011.
2. Inpatient- only data with diagnostic codes not limited 
after 2011.
3. Inpatient and outpatient data with diagnostic codes 
limited to 9 after 2011.
4. Inpatient and outpatient data with diagnostic codes 
not limited after 2011.
Risk- Adjusted Readmission Rates
We produced risk- adjusted readmission rates using a 
multivariable logistic regression model using all years of 
data between 2009 and 2013. The model(s) included 
age, sex, race, admission date, HCCs (determined 
using each of the 4 methods described previously) and 
a year- specific indicator.
Risk- Standardized Readmission Rates
To calculate the risk- standardized 30- day readmission 
rates, we used the CMS methodology. We used hierar-
chical logistic regression and all years of data between 
2009 and 2013 with year- specific indicators to calcu-
late the ratio of the number of “predicted” to the num-
ber of “expected” readmissions for each hospital and 
then multiplied that ratio by the national unadjusted re-
admission rate in that year. This approach is analogous 
to using a ratio of “observed” to “expected” such that 
a lower ratio indicates a lower than expected rate of re-
admissions/deaths, whereas a higher ratio indicates a 
higher than expected rate of deaths.16 For each cohort, 
we then calculated the risk- standardized 30- day read-
mission rate using each of the 4 comorbidity ascertain-
ment methods described previously.17
Statistical Analysis
We analyzed data from January 2009 through 
December 2013, 2 years before and 2 years after the di-
agnosis code expansion in January 2011. We calculated 
the mean International Classification of Diseases, Ninth 
Revision (ICD- 9) counts and HCCs per patient in each 
year and report the means and standard deviations for 
both AMI and HF. We then determined the absolute 
difference in risk- adjusted/risk- standardized readmis-
sion rates depending on whether diagnosis codes were 
limited and whether outpatient data were included. We 
compared these differences using chi- square testing. 
We then used a difference- in- differences approach to 
examine changes in readmission rates from the baseline 
period (2009– 2011) to the postperiod (2011– 2013), de-
pending on whether the ICD- 9 codes were limited to 9 
and whether outpatient data were included.
RESULTS
Association Between Diagnosis Code 
Expansion and Changes in Comorbidity 
Burdens
As shown in Figure 1, when the number of diagnosis 
codes allowed for inpatient hospitalizations was ex-
panded after 2011, the number of ICD- 9 and HCC con-
ditions used for risk adjustment increased for both AMI 
and HF, regardless of whether inpatient- only or inpa-
tient and outpatient data were used. The mean number 
of diagnosis codes used, at the hospital level, before 
and after 2011 show similar increases (Table S1), and 
the percentage of patients with 10 or more diagnosis 
codes on the index admission claim sharply increased 
after 2011, consistent with the abrupt step- up seen in 
Figure 1 (Table S2).
With the expansion in the number of allowed inpa-
tient diagnosis codes, after 2011, the number of ICD- 9 
and HCCs both increased significantly, although the 
magnitude of increase was larger for ICD- 9 diagnoses 
compared with HCCs (Figure 1). For example, in 2011 
in the AMI cohort, when inpatient- only data were used, 
the average number of ICD- 9 diagnoses increased by 
5.5 (from 14.1 to 19.6, +39%; P<0.001) and the aver-
age number of HCCs increased by 0.4 (from 4.0 to 4.4, 
+10%; P<0.001). For the HF cohort, when inpatient- 
only data were used, the average number of ICD- 9 
diagnoses increased by 7.2 (from 18.8 to 26.0, +38%; 
P<0.001) and the average number of HCCs increased 
by 0.4 (from 4.7 to 5.1, +9%; P<0.001).
The inclusion of outpatient data mitigated the rel-
ative increase in both ICD- 9 and HCCs, but both in-
creases remained statistically significant (Figure  1). 
When inpatient and outpatient data were used, for the 
AMI cohort, the average number of ICD- 9 diagnoses 
increased by 4.3 (from 47.8 to 51.1, +9%; P<0.001) and 
the average number of HCCs increased by 0.2 (from 
6.2 to 6.4, +3%; P<0.001). For the HF cohort, the num-
ber of ICD- 9 diagnoses increased by 5.2 (from 62.2 to 
67.4, +8%; P<0.001) and the average number of HCCs 
increased by 0.2 (from 7.4 to 7.6, +3%; P<0.001). Also 
notable, although the number of ICD- 9 and HCC con-
ditions stayed relatively flat for AMI between 2009 and 
2013, there was a general uptrend in both ICD- 9 and 
HCC conditions for the HF cohort across the same 
time period.
Inclusion of Diagnosis Code Expansion on 
Specific HCCs
Next, we determined which HCCs were most likely to be 
added to risk- adjustment models when the number of al-
lowed diagnosis codes for inpatient hospitalizations was 
expanded. As seen in Table  1, when diagnosis codes 
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95% more commonly coded for AMI readmissions and 
unspecified heart disease was 122% more commonly 
coded for HF readmissions. When inpatient and outpa-
tient data were considered, dialysis was the most com-
monly added HCC in the AMI readmission cohort (20% 
more commonly coded) and nephritis was the most 
commonly added HCC in the HF readmission cohort 
(44% more commonly coded).
Association Between Diagnosis Code 
Expansion and Readmission Rates 
Calculated Using Logistic Regression for 
Risk Adjustment
Using logistic regression for risk adjustment, between 
2009 and 2013, risk- adjusted readmission rates fell for 
both AMI and HF (Figure 2). Using inpatient- only data, 
Figure 1. ICD- 9 diagnoses and hierarchical condition categories by year, 2009 to 2013.
Estimates and standard deviations are included in Table  S2. Consistent with the Centers for Medicare and Medicaid Services 
methodology, both the index admission and the year before admission are considered in the calculation of the number if ICD- 9 
codes and HCCs that should be included in risk adjustment. AMI indicates acute myocardial infarction; HCC, hierarchical condition 
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in 2011, limiting diagnosis codes was not associated 
with a difference in 30- day AMI readmission rates (dif-
ference, −0.14%; P=0.37) or HF 30- day readmission 
rates (difference, −0.04%; P=0.70). By 2013, the dif-
ference was slightly larger (for AMI, 0.19% [P=0.20]; 
for HF, 0.10% [P=0.34]) but remained insignificant 
(Table 2).
Using inpatient and outpatient data, in 2011, for 
AMI, the difference between limited and unlimited 
models was 0.06% (P=0.70; compared with inpatient- 
only difference, 0.08%; P<0.001). Using inpatient and 
outpatient data, in 2011, for HF, the difference between 
limited and unlimited models was was 0.01% (P=0.92; 
compared with inpatient- only difference, 0.03%; 
P<0.001). In 2013, the difference between limited and 
unlimited models was 0.08% (P=0.59; compared with 
inpatient- only difference, 0.11%; P<0.001) and for HF 
was 0.02% (P=0.85; compared with inpatient- only dif-
ference, 0.08%; P<0.001).
Association Between Diagnosis Code 
Expansion and Readmission Rates 
Calculated Using the CMS Risk- 
Standardization Methodology
For both AMI and HF, the CMS risk- standardized re-
admission rates were approximately 1% higher than 
readmission rates calculated using logistic regression. 
Between 2009 and 2013, risk- standardized readmis-
sion rates fell for both AMI and HF (Figure 3).
Between 2011 and 2013, when inpatient- only data 
or inpatient and outpatient data were used, there 
were no significant differences between limited and 
unlimited model readmission rates for AMI. For HF, 
unlimited model estimates were 0.13% (P=0.04, in 
2011) to 0.10% (P=0.04, in 2013) higher. When out-
patient data were added, whereas unlimited model 
estimates remained higher for HF, the difference was 
no longer significant (2011 difference, 0.05% [P=0.42]; 
2013 difference, 0.04% [P=0.44]). For both AMI and 
HF, the difference between limited and unlimited 
models was smaller (P<0.001) when outpatient data 
were included.
Comparison of Readmission Trends Before 
and After 2011 Diagnosis Code Expansion
Using a difference- in- differences approach, we com-
pared risk- standardized readmission rates before ver-
sus after the 2011 code expansion using limited versus 
unlimited codes in the post- 2011 period. For both AMI 
and HF, there were no significant differences in esti-
mated readmission rates in the postperiod (2009 ver-
sus 2013) based on whether diagnoses codes were 
limited or not using both risk- standardized adjustment 
(Table 3) and logistic regression adjustment (Table S3).
DISCUSSION
Since 2011, when the CMS increased the number of di-
agnosis codes that could be submitted for an inpatient 
hospitalization, there has been controversy about how 
to accurately use claims data to ascertain comorbidities, 
longitudinally assess outcomes, and evaluate policies 
that span this time period. Consistent with prior work, 
this study confirms that to fairly compare the rates of 
specific comorbidities before and after 2011, researchers 
should consider limiting diagnosis codes after 2011.3,4,18 
This work also finds that when possible, outpatient data 
should be included to ensure completeness and con-
sistency of comorbidity counts. Although there appear 
to be differences in readmission rates for AMI and HF, 
depending on whether logistic regression or the CMS 
risk- standardization methodology is used, longitudinal 
estimates of changes in risk- adjusted readmission rates 
are not affected by the 2011 code expansion, whether 
using CMS methods or logistic regression methods, or 
whether including or excluding outpatient data.
The first key finding of this work is that when possi-
ble, outpatient data should be included to ensure com-
pleteness of comorbidity assessment. For AMI, when 
diagnosis codes are expanded, “dialysis” was most 
Table 1. Increase in Hierarchical Condition Category Diagnoses Observed When Diagnosis Codes Are Not Limited and 
When Outpatient Data Are Included
Inpatient- only data (percent difference) Inpatient+outpatient data (percent difference)
AMI readmission
Dialysis 95.2 Dialysis 20.4
Urinary tract disease 81.8 History of CABG 17.5
Valvular/rheumatic disease 59.7 Valvular/rheumatic disease 15.3
HF readmission
Unspecified heart disease 122.1 Nephritis 43.9
Nephritis 116.3 Drug, alcohol abuse 31.7
Psychiatric disease 115.0 Depression 30.8
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commonly added and “unspecified heart disease” 
and “nephritis” were most commonly added for HF. 
Notably, the percentage increase in specific diagno-
ses was smaller when outpatient data were included, 
underscoring how including outpatient data minimizes 
the changes associated with diagnosis code limits.
The second key finding of this work is that when 
outpatient data are added, the difference between lim-
ited and unlimited models for AMI and HF is not signif-
icant for either logistic regression or risk- standardized 
models. Although prior work has suggested that lo-
gistic regression– based risk adjustment may be im-
pacted by the 2011 diagnosis code expansion,2,3 this 
work finds that including outpatient data minimizes 
any differences in readmission rates associated with 
changes in the number of diagnosis codes included.
The third key finding of this work is, when analyzed 
longitudinally and using a difference- in- differences anal-
ysis, there does not appear to be a significant differ-
ence in either logistic regression– adjusted or the CMS 
risk- standardized readmission rates trends before and 
after the 2011 diagnosis code expansion using either 
inpatient- only or inpatient and outpatient data.
Finally, because logistic regression and the CMS 
risk- standardization produce readmission rates that 
are ~1% different on average and because these 2 
methods may be differentially affected by the 2011 
diagnosis code expansion, researchers and policy 
Figure 2. Risk- adjusted readmission rates calculated using logistic regression.
Models are adjusted for age, sex, race, year, and individual hierarchical condition comorbidities. 
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makers should use caution when comparing the re-
sults of studies that use different analytic methods.
These results highlight important considerations for 
comparing the evaluations of policies that span 2011, 
specifically the following:
1. Researchers may want to consider limiting diag-
nosis codes to 9 to allow a fair comparison of 
comorbidity counts over time.
2. When outpatient data are included, diagnosis code 
limits do not appear to significantly affect readmission 
Figure 3. Risk- standardized readmission rates calculated using the Centers for Medicare and Medicaid Services published 
methodology.
AMI indicates acute myocardial infarction; HF, heart failure; IP, inpatient; and OP, outpatient.
Table 3. Difference in Differences Analysis Comparing Risk- Standardized Readmission Trends Before Versus After the 
2011 Diagnosis Code Expansion Using 9 Versus 25 Codes in the Post- 2011 Period
2009 Risk- standardized 
readmission rate LS mean (95% CI)
2013 Risk- standardized readmission 
rate LS mean (95% CI)
LS mean P 
Value
P Value for 
interaction
Inpatient- only data
AMI, limited 0.189 (−0.181 to 0.559) 0.157 (−0.151 to 0.465) 0.189 0.88
AMI, unlimited 0.189 (−0.182 to 0.560) 0.157 (−0.151 to 0.466) 0.189
HF, limited 0.235 (−0.226 to 0.696) 0.206 (−0.197 to 0.609) 0.74 0.38
HF, unlimited 0.235 (−0.226 to 0.696) 0.206 (−0.198 to 0.610) 0.48
Inpatient+outpatient data
AMI, limited 0.189 (−0.181 to 0.559) 0.157 (−0.151 to 0.465) 0.94 0.38
AMI, unlimited 0.189 (−0.182 to 0.560) 0.157 (−0.151 to 0.466) 0.96
HF, limited 0.235 (−0.226 to 0.696) 0.206 (−0.198 to 0.609) 0.90 0.77
HF, unlimited 0.235 (−0.226 to 0.697) 0.206 (−0.198 to 0.609) 0.81
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rate estimates from either logistic regression or risk- 
standardized models.
3. When analyzed longitudinally, there does not ap-
pear to be a significant difference in either logistic 
regression– adjusted or the CMS risk- standardized 
readmission rates trends before and after the 2011 
based on whether diagnosis codes are limited or 
whether inpatient- only or inpatient and outpatient 
data are used.
4. Caution should be used when comparing analyses 
that use logistic regression to studies that use risk 
standardization to compare risk- adjusted outcomes.
Limitations
This study is unique to the Medicare population of pa-
tients hospitalized with AMI or HF and the Medicare 
risk- adjustment algorithms used for these 2 conditions. 
Thus, caution should be used when extrapolating the 
findings to other patient groups and/or risk- adjustment 
algorithms. In addition, this study does not use a con-
trol group to formally evaluate longitudinal estimates 
using 9 versus 25 diagnosis codes nor does it formally 
compare estimates using inpatient- only versus inpa-
tient and outpatient data. Although limiting to the first 
9 diagnosis codes is a methodology demonstrated in 
previous studies, this does introduce potential arbitrari-
ness because we have no knowledge about the order-
ing of the conditions listed. Typically, medical coders 
list comorbidities in order of priority based on likely 
reimbursement, but this may not always be the case.
CONCLUSIONS
For studies that span January 2011, researchers may 
want to consider limiting diagnosis codes to 9 to allow 
a fair comparison of comorbidity counts over time. 
In addition, outpatient data should be included when 
available to ensure completeness of comorbidity as-
sessment. At the same time, researchers do not need 
to restrict to 9 codes or include outpatient data for 
analyses of risk- adjusted readmission rates before and 
after 2011.
Although the 2011 diagnosis code expansion and 
the inclusion of outpatient data do not appear to sig-
nificantly impact risk- adjusted readmission rates for 
AMI or HF, when comparing studies that evaluate 
policies spanning 2011, is it important for readers, re-
searchers, and policy makers to note the methodology 
used. Direct comparison of studies that use different 
risk- adjustment methodologies may be problematic.
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AMI Risk Standardized Readmission Cohort Data Flow Diagram: 2009 - 2013
MEDPAR AMI Admissions 
Index Cohort 
(hospitalizations with principal AMI 
Dx) 
for 2009 - 2013
Dataset n = 1,462,839 Exclusions
n = 693,776
non-FFS (n = 387,172)
non-FFS post (n = 397,509)
Discharge <= 1 day (n=137,173)
Died (n = 113,251)
Transferred status (n = 67,471)
Age < 66 (n = 29,001)
CMS Hospice (n = 10,678)
Discharge AMA (n = 6,372)
Missing data (n = 58)
Initial Cohort 
365 day lookback with:





365 day lookback with:
(IP admit + OP + Part B)
















HF Risk Standardized Readmission Cohort Data Flow Diagram: 2009 - 2013
MEDPAR HF Admissions 
Index Cohort 
(hospitalizations with principal HF 
Dx) 
for 2009 - 2013
Dataset n = 3,075,536
Initial Cohort 
365 day lookback with:






non-FFS (n = 809,822)
non-FFS post (n=718,139)
Died (n = 116,658)
Transferred status (n = 
76,193)
Age < 66 (n = 36,294)
LVAD / transplant (n = 
18,805)
Discharge AMA (n = 12,547)
Study Cohort 
365 day lookback with:
(IP admit + OP + Part B)
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Table S1. Average Field Counts used to Count ICD-9 Before/After 2011. 
 
  




















n (hospitals) 1998 1998 1998 1998 1982 1982 1982 1982 
n (patients) 116850 116850 116070 116070 115887 115887 115887 115887 
mean 14.2 46.5 14.1 47.4 14.1 19.6 47.8 52.1 
median 9.0 41.0 9.0 42.0 9.0 17.0 42.0 46.0 
std dev 8.8 25.5 8.8 26.0 8.8 12.4 26.2 28.1 
min 1.0 2.0 1.0 3.0 1.0 1.0 3.0 3.0 
max 98.0 265.0 96.0 239.0 94.0 137.0 237.0 248.0 
HF 
Readmissions 
n (hospitals) 3829 3829 3770 3770 3670 3670 3670 3670 
n (patients) 346730 346730 332725 332725 317961 317961 317961 317961 
mean 18.7 59.6 18.6 61.0 18.8 26.0 62.2 67.4 
median 16.0 55.0 16.0 56.0 16.0 23.0 58.0 63.0 
std dev 10.4 28.2 10.4 28.7 10.4 14.3 29.2 31.1 
min 1.0 3.0 1.0 4.0 1.0 1.0 3.0 3.0 
max 95.0 253.0 104.0 276.0 99.0 141.0 265.0 293.0 























n (hospitals) 1954 1954 1954 1954 1910 1910 1910 1910 
n (patients) 117697 117697 117697 117697 112224 112224 112224 112224 
mean 14.0 20.9 48.4 53.8 13.8 21.2 48.7 54.4 
median 9.0 17.0 43.0 47.0 9.0 17.0 43.0 48.0 
std dev 8.7 14.1 26.6 29.6 8.6 14.3 26.6 29.8 
min 1.0 1.0 4.0 4.0 1.0 1.0 3.0 3.0 
max 100.0 149.0 252.0 281.0 84.0 145.0 235.0 281.0 
HF 
Readmissions 
n (hospitals) 3581 3581 3581 3581 3463 3463 3463 3463 
n (patients) 304913 304913 304913 304913 292740 292740 292740 292740 
mean 18.8 28.7 63.2 70.4 18.6 29.3 63.8 71.6 
median 16.0 25.0 59.0 65.0 16.0 25.0 59.0 66.0 
std dev 10.5 16.5 29.6 33.0 10.4 16.8 29.7 33.3 
min 1.0 1.0 4.0 4.0 1.0 1.0 4.0 4.0 
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Table S2. Average Index Claim Counts Before/After 2011.  
 
Year AMI Index 
Claim 
n   
9 or more 
diagnosis 
codes 
10 or more 
diagnosis 
codes 
HF Index  
Claim 
n   
9 or more 
diagnosis 
codes 
10 or more 
diagnosis 
codes 
2009 116,850  79.5% 8.1% 346,730  85.3% 6.0% 
2010 116,070  80.0% 4.6% 332,725  87.1% 4.7% 
2011 115,887   81.0% 73.1% 317,961  89.2% 81.9% 
2012 117,697   82.1% 75.1% 304,913  90.7% 85.0% 
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Table S3. Difference in Differences Analysis Comparing Logistic Regression Adjusted Readmission Trends Before vs. After the 2011 Diagnosis 























AMI (limited) 0.178 0.147 
0.031 0.034 1.0 
AMI (unlimited)  0.179 0.145 
 
HF (limited)  0.229 0.199 
0.029 0.031 1.0 
HF (unlimited)  0.229 0.200 






















AMI (limited) 0.177 0.1460 
0.031 0.032 1.0 
AMI (unlimited)  0.177 0.145 
 
HF (limited)  0.228 0.199 
0.029 0.029 1.0 
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